Herborium® Group, Inc. Announces Major Acceleration in Commercialization of Kamasutra Exotic Spirit With Herborium Natural Herbs to 1100 New Jersey Retail Stores
OCTOBER 2012 PRODUCT LAUNCH IN NEW YOUR CITY - 5 MONTHS AHEAD OF ORIGINALLY PLANNED SCHEDULE AS POPULARITY AND DEMAND ACCELERATES
Company on target for record revenues for 2012 and anticipates its first ever profit in 2013
FORT LEE, N.J., Oct. 3, 2012 /PRNewswire/ -- Herborium Group, Inc., (HBRM) www.herborium.com, a Botanical Therapeutics® Company, is very excited to announce today that due to the continuing growth of interest, Kamasutra™ exotic spirit containing Herborium's proprietary natural herbal formula will debut in New York City retail stores and upscale club venues in October this year.
This launch is five months earlier than originally planned. This development, together with the fact that Fedway (a major New Jersey liquor wholesaler) is commencing delivery of the product to the stores across New Jersey and that 1100 liquor retailers in New Jersey are on the target list, represents a significant acceleration in the distribution plans and represents a strong opportunity for Herborium to recognize increased revenues ahead of schedule.
Additional container of Kamasutra™ is expected to be ordered this year to meet this growing demand for the product.
Dr. Agnes P. Olszewski, Chairwoman and CEO of Herborium Group, Inc., stated: "The continuously rising interest in Kamasutra™ is an excellent indicator for 2013 growth of sales and market share for this unique product. We are looking forward to the future rollout of 'Lady Kama' in other States, and a strong sales and brand recognition."
Kamasutra™ "The Natural Spirit of Seduction" (www.kamasutraspirit.com) is the first-ever alcoholic beverage creation developed and endorsed by herbaceuticals science.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company sells its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.
For more information please inquire: Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.